These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage. Siddiqui MS; Yamada G; Vuppalanchi R; Van Natta M; Loomba R; Guy C; Brandman D; Tonascia J; Chalasani N; Neuschwander-Tetri B; Sanyal AJ; Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1877-1885.e5. PubMed ID: 30616027 [TBL] [Abstract][Full Text] [Related]
26. Clinical utility of noninvasive scores in assessing advanced hepatic fibrosis in patients with type 2 diabetes mellitus: a study in biopsy-proven non-alcoholic fatty liver disease. Alkayyali T; Qutranji L; Kaya E; Bakir A; Yilmaz Y Acta Diabetol; 2020 May; 57(5):613-618. PubMed ID: 31897769 [TBL] [Abstract][Full Text] [Related]
27. Step layered combination of noninvasive fibrosis models improves diagnostic accuracy of advanced fibrosis in nonalcoholic fatty liver disease. Yang M; Jiang L; Wang Y; Li X; Zou Z; Han T; Nan Y; Lu F; Zhao J J Gastrointestin Liver Dis; 2019 Sep; 28(3):289-296. PubMed ID: 31517325 [TBL] [Abstract][Full Text] [Related]
28. Non-invasive tests for liver fibrosis in NAFLD: Creating pathways between primary healthcare and liver clinics. Castera L Liver Int; 2020 Feb; 40 Suppl 1():77-81. PubMed ID: 32077617 [TBL] [Abstract][Full Text] [Related]
29. Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease. Duseja A; Singh SP; Mehta M; Shalimar ; Venkataraman J; Mehta V; Devadas K; Kar SK; Goyal O; Nagral A; Saigal S; Nijhawan S; Praharaj D; Shukla A; Sharma B; Narayanasamy K; Kumar P; Rao PN; Arora A; Mehta R; Asati P; Ranjan P; Koshy A; Alam S; Mukewar S; Mukewar S; Mohan Prasad VG; Rastogi M; Sanyal AJ Metab Syndr Relat Disord; 2022 Apr; 20(3):166-173. PubMed ID: 35085026 [No Abstract] [Full Text] [Related]
30. Is there scope to improve the selection of patients with alcohol-related liver disease for referral to secondary care? A retrospective analysis of primary care referrals to a UK liver centre, incorporating simple blood tests. Rhodes FA; Cococcia S; Patel P; Panovska-Griffiths J; Tanwar S; Westbrook RH; Rodger A; Rosenberg W BMJ Open; 2021 Jun; 11(6):e047786. PubMed ID: 34088709 [TBL] [Abstract][Full Text] [Related]
31. Accuracy of Noninvasive Fibrosis Scores to Detect Advanced Fibrosis in Patients With Type-2 Diabetes With Biopsy-proven Nonalcoholic Fatty Liver Disease. Singh A; Gosai F; Siddiqui MT; Gupta M; Lopez R; Lawitz E; Poordad F; Carey W; McCullough A; Alkhouri N J Clin Gastroenterol; 2020; 54(10):891-897. PubMed ID: 32168133 [TBL] [Abstract][Full Text] [Related]
32. Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population. Zambrano-Huailla R; Guedes L; Stefano JT; de Souza AAA; Marciano S; Yvamoto E; Michalczuk MT; Vanni DS; Rodriguez H; Carrilho FJ; Alvares-da-Silva MR; Gadano A; Arrese M; Miranda AL; Oliveira CP Ann Hepatol; 2020; 19(6):622-626. PubMed ID: 32919087 [TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of serological biomarkers for detection of non-alcoholic fatty liver disease (NAFLD) and/or advanced liver fibrosis in people living with HIV. Yanavich C; Pacheco AG; Cardoso SW; Nunes EP; Chaves U; Freitas G; Santos R; Morata M; Veloso VG; Grinsztejn B; Perazzo H HIV Med; 2021 Jul; 22(6):445-456. PubMed ID: 33529485 [TBL] [Abstract][Full Text] [Related]
34. Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease. Staufer K; Halilbasic E; Spindelboeck W; Eilenberg M; Prager G; Stadlbauer V; Posch A; Munda P; Marculescu R; Obermayer-Pietsch B; Stift J; Lackner C; Trauner M; Stauber RE United European Gastroenterol J; 2019 Oct; 7(8):1113-1123. PubMed ID: 31662868 [TBL] [Abstract][Full Text] [Related]